Products Technologies Mass Cytometry

Mass Cytometry 

Driving groundbreaking insights at the single-cell level, millions of times 

Mass cytometry, powered by CyTOF® technology, is the world’s most advanced cytometric platform. It has opened new doors to discovery and clinical research by empowering investigators to interrogate more than 50 markers simultaneously on millions of individual cells. Join the hundreds who have reimagined cytometry with CyTOF to unveil new cell types, functions and biomarkers in immunology, cancer, infectious disease and more. 



Design panel

Easily build panels with up to 50 metal-tagged antibodies and reagents using Maxpar® Panel Designer. Add barcoding to multiplex your samples for even better data quality. Or use pre-built panels to get started! 


Prepare samples

CyTOF systems provide highly multiplexed single-cell data from cell suspension samples. Standard protocols for preparing single-cell suspensions from solid or liquid tissues and tumors can be used for CyTOF sample prep. Check out our support page for staining protocols. 


Acquire data

The CyTOF XT™ system has fully automated pellet resuspension, calibration bead addition and acquisition of sample batches from the Autosampler carousel.  

The Helios™ system provides the same excellent standard of data quality as CyTOF XT but requires manual resuspension and loading of samples. 


Analyze data

CyTOF systems produce standard FCS 3.0 (Helios) or 3.1 (CyTOF XT) data files that can be analyzed with any compatible software, including FCS Express™ and Maxpar Pathsetter™


Explore these compilations of recent mass cytometry publications focused on specific areas of investigation.

February 2023: CyTOF for CAR Therapy

Read more

March 2022: Maxpar Direct Immune Profiling Assay

Read now

January 2022: COVID-19 research update

Read now

November 2021: CAR T cells

Read now

July 2021: The value of high-parameter cytometry

Read now

April 2021: Immuno-oncology

Read now

January 2021: Cancer vaccine development

Read now

November 2020: Vaccines for infectious disease

Read now

July 2020: COVID-19 disease research

Read now

Browse the latest research highlighting mass cytometry technology.